NO974840L - Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2-fenyletoksy)-2-pyridinyl]-2-propensyre - Google Patents
Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2-fenyletoksy)-2-pyridinyl]-2-propensyreInfo
- Publication number
- NO974840L NO974840L NO974840A NO974840A NO974840L NO 974840 L NO974840 L NO 974840L NO 974840 A NO974840 A NO 974840A NO 974840 A NO974840 A NO 974840A NO 974840 L NO974840 L NO 974840L
- Authority
- NO
- Norway
- Prior art keywords
- phenylethoxy
- dichlorophenyl
- pyridinyl
- thio
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9508137.8A GB9508137D0 (en) | 1995-04-21 | 1995-04-21 | Formulation |
| PCT/EP1996/001466 WO1996033174A1 (en) | 1995-04-21 | 1996-04-02 | New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO974840L true NO974840L (no) | 1997-10-20 |
| NO974840D0 NO974840D0 (no) | 1997-10-20 |
| NO309767B1 NO309767B1 (no) | 2001-03-26 |
Family
ID=10773317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974840A NO309767B1 (no) | 1995-04-21 | 1997-10-20 | Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6093828A (no) |
| EP (1) | EP0821673B1 (no) |
| JP (1) | JPH11503737A (no) |
| KR (1) | KR19990007900A (no) |
| CN (1) | CN1182418A (no) |
| AT (1) | ATE198883T1 (no) |
| AU (1) | AU707089B2 (no) |
| BR (1) | BR9608003A (no) |
| CA (1) | CA2218322A1 (no) |
| CZ (1) | CZ333797A3 (no) |
| DE (1) | DE69611670T2 (no) |
| DK (1) | DK0821673T3 (no) |
| ES (1) | ES2154818T3 (no) |
| GB (1) | GB9508137D0 (no) |
| GR (1) | GR3035494T3 (no) |
| HU (1) | HUP9801574A3 (no) |
| NO (1) | NO309767B1 (no) |
| NZ (1) | NZ307493A (no) |
| PL (1) | PL322897A1 (no) |
| PT (1) | PT821673E (no) |
| TR (1) | TR199701213T1 (no) |
| WO (1) | WO1996033174A1 (no) |
| ZA (1) | ZA963134B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9602675D0 (en) * | 1996-02-09 | 1996-04-10 | Smithkline Beecham Plc | Process |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2119467A1 (en) * | 1991-09-19 | 1993-04-01 | Pamela Anne Chambers | Pyridine compounds for treating leukotriene-related diseases |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| EP0649408A4 (en) * | 1992-06-30 | 1995-06-21 | Smithkline Beecham Corp | METHOD FOR THE PRODUCTION OF PHENYLTHIOMETHYLPYRIDINYLALKENOATS. |
| GB9313145D0 (en) * | 1993-06-25 | 1993-08-11 | Smithkline Beecham Plc | Process |
-
1995
- 1995-04-21 GB GBGB9508137.8A patent/GB9508137D0/en active Pending
-
1996
- 1996-04-02 AU AU56859/96A patent/AU707089B2/en not_active Ceased
- 1996-04-02 NZ NZ307493A patent/NZ307493A/en unknown
- 1996-04-02 JP JP8531444A patent/JPH11503737A/ja active Pending
- 1996-04-02 BR BR9608003A patent/BR9608003A/pt active Search and Examination
- 1996-04-02 HU HU9801574A patent/HUP9801574A3/hu unknown
- 1996-04-02 AT AT96914877T patent/ATE198883T1/de active
- 1996-04-02 DE DE69611670T patent/DE69611670T2/de not_active Expired - Fee Related
- 1996-04-02 CN CN96193405A patent/CN1182418A/zh active Pending
- 1996-04-02 TR TR97/01213T patent/TR199701213T1/xx unknown
- 1996-04-02 CA CA002218322A patent/CA2218322A1/en not_active Abandoned
- 1996-04-02 KR KR1019970707423A patent/KR19990007900A/ko not_active Application Discontinuation
- 1996-04-02 ES ES96914877T patent/ES2154818T3/es not_active Expired - Lifetime
- 1996-04-02 US US08/945,372 patent/US6093828A/en not_active Expired - Fee Related
- 1996-04-02 PT PT96914877T patent/PT821673E/pt unknown
- 1996-04-02 DK DK96914877T patent/DK0821673T3/da active
- 1996-04-02 PL PL96322897A patent/PL322897A1/xx unknown
- 1996-04-02 WO PCT/EP1996/001466 patent/WO1996033174A1/en not_active Application Discontinuation
- 1996-04-02 EP EP96914877A patent/EP0821673B1/en not_active Expired - Lifetime
- 1996-04-02 CZ CZ973337A patent/CZ333797A3/cs unknown
- 1996-04-19 ZA ZA9603134A patent/ZA963134B/xx unknown
-
1997
- 1997-10-20 NO NO974840A patent/NO309767B1/no not_active IP Right Cessation
-
2001
- 2001-02-28 GR GR20010400337T patent/GR3035494T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2218322A1 (en) | 1996-10-24 |
| PL322897A1 (en) | 1998-03-02 |
| ES2154818T3 (es) | 2001-04-16 |
| KR19990007900A (ko) | 1999-01-25 |
| AU5685996A (en) | 1996-11-07 |
| CN1182418A (zh) | 1998-05-20 |
| AU707089B2 (en) | 1999-07-01 |
| WO1996033174A1 (en) | 1996-10-24 |
| ATE198883T1 (de) | 2001-02-15 |
| HUP9801574A3 (en) | 1998-12-28 |
| DE69611670T2 (de) | 2001-08-23 |
| EP0821673B1 (en) | 2001-01-24 |
| DK0821673T3 (da) | 2001-06-18 |
| ZA963134B (en) | 1997-02-14 |
| NZ307493A (en) | 1998-07-28 |
| NO309767B1 (no) | 2001-03-26 |
| JPH11503737A (ja) | 1999-03-30 |
| CZ333797A3 (cs) | 1999-01-13 |
| GB9508137D0 (en) | 1995-06-07 |
| HUP9801574A2 (hu) | 1998-11-30 |
| BR9608003A (pt) | 1999-01-05 |
| EP0821673A1 (en) | 1998-02-04 |
| NO974840D0 (no) | 1997-10-20 |
| GR3035494T3 (en) | 2001-05-31 |
| US6093828A (en) | 2000-07-25 |
| PT821673E (pt) | 2001-05-31 |
| DE69611670D1 (en) | 2001-03-01 |
| TR199701213T1 (no) | 1998-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
| SE9500422D0 (sv) | New oral pharmaceutical dosage forms | |
| ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| NO20022525L (no) | Farmasöytiske formuleringer inneholdende zolmitriptan | |
| FR2731907B1 (fr) | Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique | |
| DK0556322T3 (da) | Aminosulfonylurinstof-ACAT-inhibitorer | |
| NO971182L (no) | Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen | |
| NO974840L (no) | Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2-fenyletoksy)-2-pyridinyl]-2-propensyre | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| PT783495E (pt) | Derivados de quinoxalina uteis em terapia | |
| RS49520B (sr) | Antimikrobno aktivne smeše | |
| BR9205255A (pt) | Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica | |
| ATE216702T1 (de) | Silylierungsprocess | |
| SE9502219D0 (sv) | Novel medical use | |
| MX9708089A (es) | Compuestos. | |
| NO975155L (no) | Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet | |
| FR2657005B1 (fr) | Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes. | |
| DK0808306T3 (da) | Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo | |
| UA7134C2 (uk) | Спосіб терапевтичної дії на біологічні об'єкти та пристрій для його здійснення | |
| NO974687D0 (no) | Kondenserte <beta>-carboliner | |
| TH23382A (th) | กรรมวิธีสำหรับสังเคราะห์ซับสทิทิวเทดซัลฟอกไซด์ | |
| UA6752C2 (uk) | 4-(n-бензил) амінокарбоніл-1-метилпіридиній йодид-знеболюючий засіб з інтерфероногенними, протизапальними та жарознижуючими властивостями | |
| ATE193445T1 (de) | Verwendung des alpha,alpha-diphenylessigsäure-4- (n-methyl-piperidyl)esters als spasmoanalgetikum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN OCTOBER 2002 |